Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian W Gallen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Medicine and Sport Science|September 18, 2014
Exercise for people with type 1 diabetesIan W Gallen
Diabetes Care|November 25, 2003
Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patientsIan W Gallen, Celia Carter
Diabetic Medicine : a Journal of the British Diabetic Association|February 25, 2009
Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin(1)Alistair N Lumb, Ian W Gallen
Current Opinion in Endocrinology, Diabetes, and Obesity|March 21, 2009
Diabetes management for intense exerciseAlistair N Lumb, Ian W Gallen
Clinical Medicine (London, England)|August 27, 2003
Olympic diabetesIan W Gallen, Ann Redgrave, Steven Redgrave
The Lancet. Diabetes & Endocrinology|May 24, 2017
Exercise and physical activity in patients with type 1 diabetes - Authors' replyMichael C Riddell, Ian W Gallen, Remi Rabasa-Lhoret, et al.
Diabetes Care|January 28, 2003
Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetesA Paul Lambert, Sian Ellard, Lisa I S Allen, et al.
Diabetes, Obesity & Metabolism|March 24, 2022
Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonistsThomas S J Crabtree, Karen Adamson, Hazel Reid, et al.
Diabetologia|June 14, 2020
The competitive athlete with type 1 diabetesMichael C Riddell, Sam N Scott, Paul A Fournier, et al.
The Lancet. Diabetes & Endocrinology|January 28, 2017
Exercise management in type 1 diabetes: a consensus statementMichael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Medicine and Sport Science|September 18, 2014
Exercise for people with type 1 diabetesIan W Gallen
Diabetes Care|November 25, 2003
Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patientsIan W Gallen, Celia Carter
Diabetic Medicine : a Journal of the British Diabetic Association|February 25, 2009
Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin(1)Alistair N Lumb, Ian W Gallen
Current Opinion in Endocrinology, Diabetes, and Obesity|March 21, 2009
Diabetes management for intense exerciseAlistair N Lumb, Ian W Gallen
Clinical Medicine (London, England)|August 27, 2003
Olympic diabetesIan W Gallen, Ann Redgrave, Steven Redgrave
The Lancet. Diabetes & Endocrinology|May 24, 2017
Exercise and physical activity in patients with type 1 diabetes - Authors' replyMichael C Riddell, Ian W Gallen, Remi Rabasa-Lhoret, et al.
Diabetes Care|January 28, 2003
Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetesA Paul Lambert, Sian Ellard, Lisa I S Allen, et al.
Diabetes, Obesity & Metabolism|March 24, 2022
Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonistsThomas S J Crabtree, Karen Adamson, Hazel Reid, et al.
Diabetologia|June 14, 2020
The competitive athlete with type 1 diabetesMichael C Riddell, Sam N Scott, Paul A Fournier, et al.
The Lancet. Diabetes & Endocrinology|January 28, 2017
Exercise management in type 1 diabetes: a consensus statementMichael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Pageof 1